ChemoCentryx, Inc. Announces 2011 Fourth Quarter and Full Year Financial Results

There are 1 comment on the BioSpace story from Apr 2, 2012, titled ChemoCentryx, Inc. Announces 2011 Fourth Quarter and Full Year Financial Results. In it, BioSpace reports that:

"The continued advancement of our broad pipeline in 2011 put us in a strong strategic position for the successful completion of the Company's recent initial public offering," said , Ph.D., President and Chief Executive Officer, ChemoCentryx.

Join the discussion below, or Read more at BioSpace.

Bill

Toronto, Canada

#1 May 6, 2012

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

ChemoCentryx Discussions

Title Updated Last By Comments
News IPO Preview: ChemoCentryx (May '12) May '12 Robson 1
News GSK licenses experimental arthritis treatment f... (May '12) May '12 Robson 1
News GSK Licenses RA Drug from ChemoCentryx (May '12) May '12 Robson 1
News GSK Exercises Option to License ChemoCentryx's ... (May '12) May '12 Robson 1
News GlaxoSmithKline Exercises Option to License Che... (May '12) May '12 Joan 1
News GSK obtains exclusive license to ChemoCentryx's... (May '12) May '12 Joan 1
News Drug developer ChemoCentryx has priced its IPO ... (May '12) May '12 Joan 1
More from around the web